{
"id":"mk19_bb_gm_s26",
"subspecialtyId":"gm",
"title":"Attention-Deficit/Hyperactivity Disorder",
"jsonContent":{
"type":"section",
"id":"mk19_bb_gm_s26",
"title":{
"__html":"Attention-Deficit/Hyperactivity Disorder"
},
"titleNode":{
"type":"section-title",
"hlId":"ffdf2b",
"children":[
"Attention-Deficit/Hyperactivity Disorder"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_gm_s26_1",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"bbf432",
"children":[
{
"type":"abbreviation",
"title":"attention-deficit/hyperactivity disorder",
"children":[
"ADHD"
]
},
" usually first manifests in childhood and is characterized by inattention, hyperactivity, and impulsivity with functional impairment in at least two settings (home, work, school). ADHD is more prevalent in patients with mood disorders and substance use disorder."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_gm_s26_2",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"4edaa9",
"children":[
"Treat ADHD with stimulants (e.g., amphetamine or methylphenidate), but beware of the potential for abuse and use with caution in patients with hypertension or cardiovascular disease. Atomoxetine is an ",
{
"type":"abbreviation",
"title":"serotonin-norepinephrine reuptake inhibitor",
"children":[
"SNRI"
]
},
" approved for treatment of ADHD in adults. ",
{
"type":"abbreviation",
"title":"cognitive behavioral therapy",
"children":[
"CBT"
]
},
" may be beneficial alone or used as an adjunctive therapy."
]
}
]
}
]
},
"tablesContent":{
}
}